The principal features of obsessive-compulsive disorder are obsessions, recurrent intrusive thoughts or images, and compulsions, recurrent stereotyped behaviours which result from obsessions. Patients Surprisingly, obsessive-compulsive disorder is one of the psychiatric conditions which has been most studied with functional neuroimaging techniques (SPECT and PET). This partly reflects the striking and relatively consistent results that emerged from early studies, in contrast with initial work in other psychiatric disorders. Another factor may be that patients with obsessive-compulsive disorder are relatively cooperative, and tend to be more willing and able to tolerate lengthy scanning procedures than, for example, patients who are psychotic.
Positron emission tomography and SPECT were initially used to examine regional cerebral metabolism or blood flow in the resting state, and, whereas there has been some variation in the precise location and laterality of differences, most studies have reported increased activity in the inferior prefrontal (orbitofrontal) or anterior cingulate cortex, or the neostriatum, compared with controls.'>'7 Because many of these investigations involved euthymic, drug free patients, the differences are unlikely to reflect confounding effects of concurrent depression or medication. However, as the patients were scanned at rest, it is unclear whether the findings reflect the presence of obsessive-compulsive symptoms or enduring features of the condition-that is, abnormalities of state or trait. Subsequent work involved scanning before and after treatment, and found that symptomatic improvement was associated with a reduction in metabolism (depending on the study) in inferior prefrontal, cingulate, or striatal regions areas where activity had initially been increased.27 "I This raised the possibility that the increased activity before treatment was associated with the presence of obsessive-compulsive phenomena, as opposed to the diagnosis itself.
The relation between symptoms and activity has been explicitly examined in studies which involve the provocation of obsessive-compulsive phenomena by exposing patients to feared stimuli, such as "contaminated" objects in those prone to hand washing rituals. One study compared regional cerebral blood flow during provoked and neutral states,5" and another used a correlational design, with symptom intensity experimentally manipulated in a graded fashion across a series of scans. 52 40 41 region.
Perspectives on the pathophysiology of obsessive-compulsive disorder have also been altered by the recent discovery that antidepressants with a principle action at serotonergic synapses such as clomipramine, fluoxetine, and fluvoxamine-have an ameliorating effect on obsessional symptoms.42-45 This is not merely secondary to their effect on mood,4647 and these drugs are more effective than non-serotonergic antidepressants.6'849 Whether the extent of their impact on obsessive-compulsive phenomena depends on the inhibition of transmitter reuptake or effects on receptor densities is unclear, but their effectiveness suggests that obsessive-compulsive disorder involves an abnormality of serotonergic transmission. This is consistent with data from neuroendocrine studies, which indicate that patients with obsessive-compulsive disorder show reduced hypothalamic sensitivity to serotonergic probes such as D-fenfluramine.50 52 Serotonergic antidepressants are now an established part of the management of obsessive-compulsive disorder, although they usually lead to an improvement in the condition rather than complete remission53
and the benefits of their use in the long term have yet to be fully evaluated.54
Although pharmacotherapy has emerged as a valuable tool in the management of obsessive-compulsive disorder, behaviour therapy (typically involving graded exposure to feared stimuli and prevention of subsequent avoidance and rituals), remains arguably the most effective means of treatment,55 although it is critically dependent on patient motivation. Little is known of how it may affect brain function, but a recent study found that successful behaviour therapy, like successful treatment with serotonergic antidepressants, was associated with a reduction in striatal hypermetabolism.29 This suggests that both forms of treatment may act on a common neural substrate, an intriguing hypothesis which merits further exploration with neuroimaging.
One reason why the data from functional neuroimaging studies in obsessive-compulsive disorder have generated such interest is that they are broadly consistent with the clinical findings which implicate frontocingulate and striatal regions in its pathophysiology. Moreover, these areas are anatomically connected in a corticothalamostriatal loop, comprising a neural network which may normally be involved in switching between patterns of behaviour.56 Dysfunction in this network could thus underlie obsessive-compulsive phenomena.
At present the evidence linking this network with a disturbance in serotonergic dysfunction in obsessive-compulsive disorder is largely indirect. Serotonergic neurons in the Raphe nuclei project to the relevant cortical and striatal areas, but also send axons to most other telencephalic regions.57 58 Depletion of serotonin in experimental animals leads to increased expression of normally suppressed behaviours,59 whereas treatment of obsessive compulsions with serotonergic antidepressants seems to reduce metabolic overactivity in frontocingulate and striatal regions, suggesting a serotonergic effect on activity at these sites. In the absence of suitable PET or SPECT ligands, it has not yet been possible to examine the distribution of serotonin receptors in obsessive-compulsive disorder, but such compounds should soon be available.606'
The interaction between serotonergic inputs and corticostriatal areas could be explored more directly by investigating the modulatory effects of serotonergic agents on neural responses to symptom provocation, using a combined behavioural and pharmacological challenge. This strategy has been successfully employed in other contexts.62
In summary, there is now much evidence pointing to the importance of frontocingulate and striatal areas and serotonergic transmission in obsessive-compulsive disorder, and this has greatly advanced our understanding of the condition. These findings challenge traditional perspectives on obsessive-compulsive disorder, which has generally been regarded as a "neurotic" condition, with the tacit implication that biological factors play a minor role in its pathogenesis. At the same time, this should not divert attention from the importance of psychological processes in obsessive-compulsive disorder, as underlined by the effectiveness of behaviour therapy,55 and the striking finding that it may lead to similar changes in regional brain activity as does pharmacological treatment.29
Nevertheless, recognition of the role of biological factors in obsessive-compulsive disorder has profoundly increased public awareness about a condition which was,
